The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease

Regulatory Peptides

Volumn 121, Issue 1-3, 2004, Pages 129-136

  Heringlake, Matthias ^a   Kox, Thomas ^b   Uzun, Orhan ^b   Will, Barbara ^a   Bahlmann, Ludger ^a   Klaus, Stephan ^a   Eleftheriadis, Sawas ^a   Armbruster, Franz Paul ^c   Franz, Norbert ^b   Kraatz, Ernst ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Schuchtermann Klinik   (Germany)

^c IMMUNDIAGNOSTIK AG   (Germany)

Author keywords

Cardiovascular surgery; Coronary disease; Heart failure; Hemodynamics; Hormones; Right heart catheterization

Indexed keywords

UROTENSIN II;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE FILLING PRESSURE; HEMODYNAMICS; HUMAN; IMMUNOREACTIVITY; LUNG CAPILLARY PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGED; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FEMALE; HEART CATHETERIZATION; HEART VENTRICLES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; UROTENSINS; VENTRICULAR PRESSURE;

EID: 3142634520     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.04.012     Document Type: Article

References (26)

1. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature. 401:1999;282-286
2. Matsushita M., Shichiri M., Imai T., Iwashina M., Tanaka H., Takasu N., et al. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J. Hypertens. 19:2001;2185-2190
3. Nothacker H.P., Wang Z., McNeill A.M., Saito Y., Merten S., O'Dowd B., et al. Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat. Cell. Biol. 1:1999;383-385
4. Maguire J.J., Kuc R.E., Davenport A.P. Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br. J. Pharmacol. 131:2000;441-446
5. Stirrat A., Gallagher M., Douglas S.A., Ohlstein E.H., Berry C., Kirk A., et al. Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries. Am. J. Physiol. 280:2001;H925-H928
6. Hillier C., Berry C., Petrie M.C., O'Dwyer P.J., Hamilton C., Brown A., et al. Effects of urotensin II in human arteries and veins of varying caliber. Circulation. 103:2001;1378
7. Russell F.D., Molenaar P., O'Brien D.M. Cardiostimulant effects of urotensin-II in human heart in vitro. Br. J. Pharmacol. 132:2001;5-9
8. Watanabe T., Pakala R., Katagiri T., Benedict C.R. Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation. J. Hypertens. 19:2001;2191-2196
9. Zou Y., Nagai R., Yamazaki T. Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats. FEBS Lett. 508:2001;57-60
10. Douglas S.A., Tayara L., Ohlstein E.H., Halawa N., Giaid A. Congestive heart failure and expression of myocardial urotensin II. Lancet. 359:2002;1990-1997
11. Richards A.M., Nicholls M.G., Lainchbury J.G., Fisher S., Yandle T.G. Plasma urotensin II in heart failure. Lancet. 360:2002;545-546
12. Dschietzig T., Bartsch C., Pregla R., Zurbrugg H.R., Armbruster F.P., Richter C., et al. Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure. Regul. Pept. 110:2002;33-38
13. Zhong P., Li Z.L., Wu H.C., Tang C.S., Lu Q. Clinical study of changes of urotensin II in patients with congestive heart failure. Di Yi Junyi Daxue Xuebao. 23:2003;121-123
14. Buckberg G.D. Cardioplegia solutions - unproven herbal approach versus tested scientific study. Semin. Thorac. Cardiovasc. Surg. 13:2001;52-55
15. Sundsfjord J.A., Thibault G., Larochelle P., Cantin M. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J. Clin. Endocrinol. Metab. 66:1988;605-610
16. Pfister R., Scholz M., Wielckens K., Erdmann E., Schneider C.A. The value of natriuretic peptides NT-pro-BNP and BNP for the assessment of left-ventricular volume and function. A prospective study of 150 patients. Dtsch. Med. Wochenschr. 127:2002;2605-2609
17. Ng L.L., Loke I., O'Brien R.J., Squire I.B., Davies J.E. Plasma urotensin in human systolic heart failure. Circulation. 106:2002;2877-2880
18. Hobbs F.D., Davis R.C., Roalfe A.K., Hare R., Davies M.K., Kenkre J.E. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ. 324:2002;1498
19. Groenning B.A., Nilsson J.C., Sondergaard L., Pedersen F., Trawinski J., Baumann M., et al. Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations. Am. Heart J. 143:2002;923-929
20. Otterstad J.E., St John Sutton M.G., Froeland G.S., Holme I., Skjaerpe T., Hall C. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function. Eur. Heart J. 23:2002;1011-1020
21. Richardt G., Tolg R. Cellular sequelae of myocardial ischemia. Z. Kardiol. 86(Suppl. 1):1997;23-32
22. Totsune K., Takahashi K., Arihara Z., Sone M., Satoh F., Ito S., et al. Role of urotensin II in patients on dialysis. Lancet. 358:2001;810-811
23. Totsune K., Takahashi K., Arihara Z., Sone M., Ito S., Murakami O. Increased plasma urotensin II levels in patients with diabetes mellitus. Clin. Sci. (Lond). 104:2003;1-5
24. Heller J., Schepke M., Neef M., Woitas R., Rabe C., Sauerbruch T. Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension. J. Hepatol. 37:2002;767-772
25. Terazawa E., Dohi S., Akamastsu S., Ohata H., Shimonaka H. Changes in calcitonin gene-related peptide, atrial natriuretic peptide and brain natriuretic peptide in patients undergoing coronary artery bypass grafting. Anaesthesia. 58:2003;223-232
26. Russell F.D., Meyers D., Galbraith A.J., Bett N., Toth I., Kearns P., et al. Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. Am. J. Physiol. 285:2003;H1576-H1581